| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Clostridium botulinum Botulinum neurotoxin type C1 |
|---|
| Description | 2-428. Partial. MW: 64.87kD. Purity >90% as determined by SDS-PAGE. Botulinum toxin acts by inhibiting neurotransmitter release. It binds to peripheral neuronal synapses, is internalized and moves by retrograde transport up the axon into the spinal cord where it can move between postsynaptic and presynaptic neurons. It inhibits neurotransmitter release by acting as a zinc endopeptidase that cleaves syntaxin. |
|---|
| Size | 0.01 mg (E-Coli), 0.05 mg (E-Coli), 0.1 mg (E-Coli), 0.2 mg (E-Coli), 0.05 mg (Yeast) |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [Botulinum neurotoxin type C1; Botulinum neurotoxin type C1; Bontoxilysin-C1] |
|---|
| Gene, Accession, CAS # | BoNT/C1; BoNT/C1, Accession: P18640.2 |
|---|
| Catalog # | MBS1065250 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Clostridium botulinum Botulinum neurotoxin type C1 from MYBIOSOURCE INC. |
|---|
| Product Specific References | Nucleotide sequence of Clostridium botulinum C1 neurotoxin.Hauser D., Eklund M.W., Kurazona H., Binz T., Niemann H., Gill D.M., Boquet P., Popoff M.R.Nucleic Acids Res. 18:4924-4924(1990) The complete nucleotide sequence of the gene coding for botulinum type C1 toxin in the C-ST phage genome.Kimura K., Fujii N., Tsuzuki K., Murakami T., Indoh T., Yokosawa N., Takeshi K., Syuto B., Oguma K.Biochem. Biophys. Res. Commun. 171:1304-1311(1990) Establishment of a monoclonal antibody recognizing an ant |
|---|
| 产品资料 |
|
|